Protagenic Therapeutics Inc Stock price
Is Protagenic Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Protagenic Therapeutics Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Protagenic Therapeutics Inc forecast:
Analyst Opinions
7 Analysts have issued a Protagenic Therapeutics Inc forecast:
Don't miss a Thing! We will send you all news about Protagenic Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Protagenic Therapeutics Inc Stock News
Company Profile
Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
| Head office | United States |
| Employees | 3 |
| Founded | 1994 |
| Website | protagenic.com |


